CCI vs PAHC · P/E 40, rev $2.02B vs P/E 13, rev $1.52B
Crown Castle (CCI) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CCI revenue for 2026-06-30 was $2.02B. Net income was $245.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the CCI and PAHC stock pages for the full models.
Not investment advice.